Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Resources
Thought Leadership
Oct 12, 2023
Using hybrid PKPD/ML models to accurately predict risk of neutropenia
Thought Leadership
Aug 15, 2023
Simulation Demonstrates Potential Effectiveness of Model-Informed Precision Dosing for Heparin
Scientific Publications
Aug 10, 2023
Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic / machine learning model
Thought Leadership
Jul 3, 2023
How Clinical Decision Support for Precision Dosing Can Enhance Healthcare Equity and Inclusion
Scientific Publications
Mar 8, 2023
Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care Data
Scientific Publications
Mar 8, 2023
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation
Scientific Publications
Mar 8, 2023
Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set
Thought Leadership
Feb 28, 2023
What Does 2023 Hold for Biopharma? Part 5: Technological Advances
Thought Leadership
Jan 3, 2023
The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences
2
3
4
5
6
